Patents by Inventor Michael VIDNE

Michael VIDNE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11015229
    Abstract: Methods for determining various oncogenic-related indexes of patient specific mutations are provided. The methods provided allow determination and grading of various patient specific mutations and qualitative and quantitative determination of various related oncogenic indexes.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: May 25, 2021
    Assignee: NOVELLUSDX LTD.
    Inventors: Gabi Tarcic, Yoram Altschuler, Michael Vidne
  • Publication number: 20200370035
    Abstract: The invention relates to methods for performing in vitro site-directed mutagenesis of a targeted gene or genes. In another aspect, the invention includes in vitro site-directed mutagenesis kits comprising a ribonucleotide particle (RNP), an oligonucleotide, a buffer, a cell-free extract, and instructional material for use thereof.
    Type: Application
    Filed: June 11, 2020
    Publication date: November 26, 2020
    Applicants: Christiana Care Health Services, Inc., Novellusdx Ltd.
    Inventors: Eric B. Kmiec, Michael Vidne, Gabi Tarcic
  • Publication number: 20190359973
    Abstract: The invention relates to methods for performing in vitro site-directed mutagenesis of a targeted gene or genes. In another aspect, the invention includes in vitro site-directed mutagenesis kits comprising a ribonucleotide particle (RNP), an oligonucleotide, a buffer, a cell-free extract, and instructional material for use thereof.
    Type: Application
    Filed: January 9, 2018
    Publication date: November 28, 2019
    Applicants: Christiana Care Health Services, Inc., Novellusdx Ltd.
    Inventors: Eric B. Kmiec, Michael Vidne, Gabi Tarcic
  • Publication number: 20170159138
    Abstract: Methods for determining various oncogenic-related indexes of patient specific mutations are provided. The methods provided allow determination and grading of various patient specific mutations and qualitative and quantitative determination of various related oncogenic indexes.
    Type: Application
    Filed: July 20, 2015
    Publication date: June 8, 2017
    Inventors: Gabi TARCIC, Yoram ALTSCHULER, Michael VIDNE